Regeneron Pharmaceuticals (REGN) Ownership - Who owns Regeneron Pharmaceuticals?

Industry: @Biotechnology

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

777 Old Saw Mill River Road

Phone

+1 914 847-7000

Employees

13450

Web

https://www.regeneron.com

Details

Group

Domestic Stock Funds

Fundamentals

REGN

Capitalization

125B

P/E Ratio

29.96

Risk (Beta)

0.45

Dividend Yield

N/A

Total Cash

9.81B

Total Cash/Share

88.98

Total Debt

2.7B

Total Debt/Equity

24.02

Projected Growth (PEG Ratio)

1.54

Revenue/Share (as % of the share price)

117.91%

Revenue

13.5B

ROE

N/A

Book Value

28.2B

P/B Ratio

4.42

Cash Flow

N/A

Earnings

40.31

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

100K

Current Ratio

5.44

Current Revenue Per Employee

250218.67

Dividends Per Share - Security

N/A

EBITDA

5.11B

Float

N/A

Float - Current

N/A

Gross Income Margin

86.46

Revenue To Assets

12.95

Shares Held By Institutions

263B

Shares Outstanding - Current

110M

Total Liabilities

7.88B

Total Volume MTD

N/A

Value

-1

Gain YTD

31.010

View a ticker or compare two or three

Compare

REGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For REGN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for REGN (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology